Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Quantification of fibrinogen-to-pre-albumin ratio provides an integrating parameter for differential diagnosis and risk stratification of early-stage colorectal cancer

Fig. 4

Prognosis and predicted efficacy of FPR and clinical characteristics in identifying a recurrence of stage II CRC patients. Recurrence (A) and death rate (B) in clinical low-risk (LR) and high-risk (HR) patients with or without chemotherapy (CT); C, D Kaplan–Meier (K–M) curve of survival in HR-CT, HR-CT(non), LR subgroups; E, F K–M curve of survival in HR-CT patients with high- and low-FPR and LR subgroup; G, H K–M curve of survival in HR-CT(non) patients with high- and low-FPR and LR subgroup; I, J recurrence and death rate in HR-CT group with H-(a) and L-(b) FPR, LR group with H-FPR (c), HR-CT(non) with L-(d) and H-(e) FPR; K, L time-dependent ROC of FPR and common clinical characteristics in predicting the 3 years RFS and OS; **p < 0.01; ns no significance

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us